Angeliki Siapkara

Senior Regulatory Affairs Director & Global Regulatory Lead,
AstraZeneca

Dr Siapkara is a Senior Regulatory Affairs Director and the global regulatory lead for AstraZeneca’s Paediatric Oncology Development Team. She has been working in paediatric drug development and relative policy activities for over 18 years. She obtained her medical degree from the University of Athens, and completed her postgraduate qualification in Orthopaedic Surgery with a special interest in Paediatrics at hospitals in Athens, Glasgow and at Great Ormond Street Hospital. In 2010 she obtained a MSc in International Child Health from University College London. Between 2008 and 2023 Dr Siapkara led the MHRA Paediatric Unit which delivered the implementation of regulatory activities for innovating paediatric medicines including PIPs, paediatric clinical trials and marketing authorisations and paediatric pharmacovigilance. During that time, Dr Siapkara was the UK delegate at EMA’s Paediatric Committee (PDCO) and member of the CMDh/EMA Working Party on Paediatric Regulation.